An open-label, single-dose bioavailability study of the pharmacokinetics of CAT-354 after subcutaneous and intravenous administration in healthy males

Chad K. Oh; Raffaella Faggioni; Feng Jin; Lorin K. Roskos; Bing Wang; Claire Birrell; Rosamund Wilson; Nestor A. Molfino

首页> 外文期刊>British Journal of Clinical Pharmacology >An open-label, single-dose bioavailability study of the pharmacokinetics of CAT-354 after subcutaneous and intravenous administration in healthy males

【24h】

An open-label, single-dose bioavailability study of the pharmacokinetics of CAT-354 after subcutaneous and intravenous administration in healthy males

机译：一项公开标签，单剂量生物利用度研究健康男性皮下和静脉内给药后CAT-354的药代动力学

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT

机译：关于此主题的已知知识

著录项

来源
《British Journal of Clinical Pharmacology》 |2010年第6期|p.645-655|共11页
作者
Chad K. Oh; Raffaella Faggioni; Feng Jin; Lorin K. Roskos; Bing Wang; Claire Birrell; Rosamund Wilson; Nestor A. Molfino;
展开▼
作者单位

MedImmune, LLC, Gaithersburg, MD, USA and;

MedImmune, LLC, Gaithersburg, MD, USA and;

MedImmune, LLC, Gaithersburg, MD, USA and;

MedImmune, LLC, Gaithersburg, MD, USA and;

MedImmune, LLC, Gaithersburg, MD, USA and;

MedImmune, LLC, Gaithersburg, MD, USA and;

SPICA Consultants, Ltd, Marlborough, UK;

MedImmune, LLC, Gaithersburg, MD, USA and;

展开▼
收录信息
原文格式 PDF
正文语种
中图分类
关键词
antibody; asthma; bioavailability; CAT-354; half-life; IL-13;

机译：抗体;哮喘;生物利用度;CAT-354;半衰期;IL-13;
入库时间 2022-08-17 14:09:21

相似文献

外文文献
中文文献
专利

1. An open-label, single-dose bioavailability study of the pharmacokinetics of CAT-354 after subcutaneous and intravenous administration in healthy males [J] . Chad K. Oh, Raffaella Faggioni, Feng Jin, British Journal of Clinical Pharmacology . 2010,第6期

机译：一项公开标签，单剂量生物利用度研究健康男性皮下和静脉内给药后CAT-354的药代动力学
2. An open-label, single-dose bioavailability study of the pharmacokinetics of CAT-354 after subcutaneous and intravenous administration in healthy males [J] . Chad K. Oh, Raffaella Faggioni, Feng Jin, British journal of clinical pharmacology . 2010,第6期

机译：一项公开标签，单剂量生物利用度研究健康男性皮下和静脉内给药后CAT-354的药代动力学
3. An open-label, single-dose bioavailability study of the pharmacokinetics of CAT-354 after subcutaneous and intravenous administration in healthy males [J] . Chad K. Oh, Raffaella Faggioni, Feng Jin, British journal of clinical pharmacology . 2010,第6期

机译：一项公开标签，单剂量生物利用度研究健康男性皮下和静脉内给药后CAT-354的药代动力学
4. Pharmacokinetic and bioequivalencecomparison between capsule and conventionaltablet formulations of paeonol: an open-label,single-dose, randomized-sequence,two-period crossover study in healthyChinese male volunteers [C] . Jianheng Li, Xinghong Zhang, Lifeng Hou, International Conference on Human Health and Medical Engineering. . 2014

机译：芍药醇胶囊和常规组配方的药代动力学和生物等效作用：健康女性志愿者的开放标签，单剂量，随机序列，双周交叉研究
5. Pharmacokinetic Evaluation of a Novel Compound, SN79, a Putative Sigma-2 Receptor Antagonist, by Intravenous and Oral Administration in Rats. [D] . Vinnakota, Harsha. 2011

机译：通过大鼠静脉内和口服给药对新型化合物SN79（一种公认的Sigma-2受体拮抗剂）进行药代动力学评估。
6. An open-label single-dose bioavailability study of the pharmacokinetics of CAT-354 after subcutaneous and intravenous administration in healthy males [O] . Chad K Oh, Raffaella Faggioni, Feng Jin, 2010

机译：一项公开标签单剂量生物利用度研究健康男性皮下和静脉内给药后CAT-354的药代动力学
7. An open-label, single-dose bioavailability study of the pharmacokinetics of CAT-354 after subcutaneous and intravenous administration in healthy males [O] . Oh, Chad K, Faggioni, Raffaella, Jin, Feng, 2010

机译：一项公开标签，单剂量生物利用度研究健康男性皮下和静脉内给药后CAT-354的药代动力学

An open-label, single-dose bioavailability study of the pharmacokinetics of CAT-354 after subcutaneous and intravenous administration in healthy males

摘要

著录项

相似文献

相关主题

期刊订阅